BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:California Life Sciences
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260730T083000
DTEND;TZID=America/Los_Angeles:20260730T100000
DTSTAMP:20260615T164620Z
CREATED:20260615T164620Z
LAST-MODIFIED:20260615T164620Z
UID:10001108-1785400200-1785405600@www.califesciences.org
SUMMARY:Peptides\, Proximity\, and Precision: The Expanding Druggable Proteome
DESCRIPTION:Drug discovery is ever-evolving with simultaneous advances in modality\, mechanism\, and druggable landscape. The assets entering the clinic in 2025 mark a genuine striking point across multiple fronts. A modality once confined to injectables is routinely going oral\, expanding opportunities to indications long reserved for biologics. Induced-proximity and ternary complex-stabilization mechanisms have progressed from preclinical concepts to established pipeline strategies\, disarming targets that resisted decades of pursuit via traditional approaches. Mature target classes are yielding first- and best-in-class assets as advances in selectivity\, binding kinetics\, and molecule design catch up to the underlying biology. And the oldest drug target family is having a second act\, with structure-enabled design unlocking therapeutic opportunities few expected to unfold. This talk highlights ten recent programs across macrocyclic peptides\, Class B GPCRs\, functionally-differentiated small molecules\, and proximity pharmacology\, highlighting the chemical matter\, target biology\, and design strategies that distinguish them and what insights/lessons discovery teams can leverage. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/peptides-proximity-and-precision-the-expanding-druggable-proteome/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/peptides-proximity-and-precision-the-expanding-druggable-proteome/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260729T090000
DTEND;TZID=America/Los_Angeles:20260729T100000
DTSTAMP:20260611T234345Z
CREATED:20260611T234345Z
LAST-MODIFIED:20260611T234345Z
UID:10001104-1785315600-1785319200@www.califesciences.org
SUMMARY:Footprints Without Footwork: Automated Benchtop HRPF for Binding Partners and Interfaces
DESCRIPTION:About this Webinar\nEvery protein leaves a footprint — the surface-exposed side chains that are accessible when it folds\, when it binds\, when it changes shape. Hydroxyl radical protein footprinting (HRPF) reads those footprints by oxidising the exposed residues and leaving the buried ones alone — a structural mass spectrometry technique that runs on standard laboratory equipment plus a benchtop Fenton reaction. Done by hand it is labor-intensive: multiple radical concentrations\, replicate reactions\, and dose-response curves that are sensitive to pipetting variability. Manual HRPF also limits the technique in scope — applying it across the dozens of pulldowns needed to characterise a complex becomes impractical. \nIn this webinar we show how moving the workflow onto the Opentrons Flex liquid handler tightens reproducibility and lifts throughput\, and how applying that automated workflow to affinity-purified protein complexes lets you identify binding partners and map their interaction interfaces in the same experiment. \nWhat you’ll learn in this webinar:\n\nHRPF can be performed using standard laboratory equipment to probe surface-accessible amino acids on proteins and protein complexes\nAutomating HRPF reactions on the Opentrons Flex reduces variability and increases throughput\nPerforming HRPF reactions on affinity-purified protein complexes can provide insights into binding partners and interfaces simultaneously\n\nOur Speaker:\nTyler Cropley is a Research Scientist in the Proteomics Laboratory at NYU Langone Health under the supervision of Dr. Beatrix Ueberheide. His work focuses on using mass spectrometry-based methods to study higher-order protein structure. He earned his PhD from Florida State University under the supervision of Dr. Christian Bleiholder. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/nyu-footprint-2026/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/nyu-footprint-2026/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260728T120000
DTEND;TZID=America/Los_Angeles:20260728T130000
DTSTAMP:20260709T155908Z
CREATED:20260709T155908Z
LAST-MODIFIED:20260709T155908Z
UID:10001123-1785240000-1785243600@www.califesciences.org
SUMMARY:Built to Scale\, Positioned to Sell: Navigating MedTech Manufacturing Readiness and M&A
DESCRIPTION:Manufacturing readiness is one of the clearest signals of whether a MedTech company is truly built to scale—and ultimately\, to sell. For early-stage life science and medical device ventures\, initial decisions around product design\, quality systems\, and supply chain planning can either accelerate commercialization or create devastating\, costly barriers to an exit. \n​Presented by PDV MedTech\, and University Lab Partners\, this panel brings together the vital pillars of the MedTech ecosystem: investment banking\, advanced manufacturing leadership\, and venture acceleration. Together\, our experts will explore how operational readiness directly impacts valuation\, investor confidence\, and M&A diligence outcomes. Attendees will gain actionable insights into bridging the gap between clinical validation and commercial scalability\, minimizing technical debt\, and making strategic choices today that maximize optionality and exit value tomorrow. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/navigating-medtech-manufacturing-readiness-and-ma/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/navigating-medtech-manufacturing-readiness-and-ma/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260723T160000
DTEND;TZID=America/Los_Angeles:20260723T180000
DTSTAMP:20260716T163344Z
CREATED:20260716T163344Z
LAST-MODIFIED:20260716T163344Z
UID:10001128-1784822400-1784829600@www.califesciences.org
SUMMARY:VRP Labs Summer Happy Hour
DESCRIPTION:Join us at Valley Research Park for a Summer Happy Hour! Connect with others in the biotech startup community\, enjoy appetizers and drinks\, and join in on the summer fun. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/vrp-labs-summer-happy-hour/
LOCATION:Valley Research Park\, 319 N. Bernardo Avenue\, Mountain View\, CA\, 94043\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T140000
DTEND;TZID=America/Los_Angeles:20260722T150000
DTSTAMP:20260610T174519Z
CREATED:20260610T174519Z
LAST-MODIFIED:20260610T174519Z
UID:10001102-1784728800-1784732400@www.califesciences.org
SUMMARY:From Clinical to Commercial: Talent Strategies for Biopharma Growth
DESCRIPTION:Early indications in 2026 are pointing towards a slight recovery in the biopharma job market. Join industry hiring experts for a data-informed discussion on where the life sciences job market stands today\, what trends we are witnessing in hiring and how hiring managers and HR and talent acquisition professionals can navigate shifts towards commercial readiness and/or building out commercial teams. \nThis webinar will provide a clear-eyed assessment of current hiring conditions across biopharma\, exploring how the economic climate is impacting workforce development and how hiring practices are evolving as organizations prepare to take products to market. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-clinical-to-commercial-talent-strategies-for-biopharma-growth/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/from-clinical-to-commercial-talent-strategies-for-biopharma-growth/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T120000
DTEND;TZID=America/Los_Angeles:20260722T130000
DTSTAMP:20260709T155653Z
CREATED:20260709T155653Z
LAST-MODIFIED:20260709T155653Z
UID:10001122-1784721600-1784725200@www.califesciences.org
SUMMARY:How to Evaluate if the Model Actually Works
DESCRIPTION:Every AI tool arrives with an impressive number attached. The number is usually real but whether it means anything is another matter. \n​This 60-minute session teaches life-sciences researchers and managers how to evaluate a performance claim for AI models. We open with a model that scored well in its own hospital but fell apart in the next one. You’ll leave with a five-question checklist that exposes a weak claim in a few minutes. \n​The session ends with a hands-on exercise where we examine two models and decide which to deploy. \n​Who this is for: Life science professionals\, managers\, researchers\, and anyone in life sciences who is looking to evaluate AI tools. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-evaluate-if-the-model-actually-works/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/how-to-evaluate-if-the-model-actually-works/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T090000
DTEND;TZID=America/Los_Angeles:20260722T100000
DTSTAMP:20260611T234114Z
CREATED:20260611T234114Z
LAST-MODIFIED:20260611T234114Z
UID:10001103-1784710800-1784714400@www.califesciences.org
SUMMARY:A Hybrid Fragmentation Strategy for Modified Oligos
DESCRIPTION:About this webinar\nMass-spectrometric sequencing of therapeutic oligonucleotides is constrained by the choice of fragmentation method. Electron-transfer dissociation (ETD) struggles to fully fragment modified backbones — particularly locked nucleic acids (LNA) — and higher-energy collisional dissociation (HCD) produces dense spectra that are slow to interpret and prone to coverage gaps. For antisense oligos that combine LNA modifications with phosphorothioate (PS) backbones\, neither approach on its own delivers reliable end-to-end coverage. \nThis webinar presents a hybrid fragmentation approach that combines ETD and HCD in a single Orbitrap scan (EThcD)\, applied across a panel of 16-mer modified oligonucleotides — LNA-containing antisense oligos\, full PS and PO backbones\, and PS/PO mixtures. The method gives full sequence coverage from w-ions alone\, with cleaner spectra than HCD and a controlled\, a/w- and d/z-dominant fragment pattern suitable for automated assignment in Byos. Kevin will also walk through the Byos processing recipe used to interpret the data and the optimal EThcD energy identified for the 16-mer panel. \nKey Takeaways\n\nA single Orbitrap scan that covers modified oligos end-to-end. EThcD on highly-charged anionic precursors yields full w-ion coverage on LNA-containing antisense oligonucleotides and PS-backbone samples where ETD and HCD alone leave gaps.\nA counter-intuitive PS-versus-PO finding. Phosphorothioate backbones fragment more efficiently under EThcD than phosphodiester backbones — with direct implications for impurity screening in PS therapeutics.\nA practical EThcD processing recipe in Byos. Recommended energy settings\, fragment-type configuration\, and a strict-then-lenient pass strategy for confident sequence coverage and impurity detection.\n\nSpeaker\nKevin Hes — PhD candidate\, Division of BioAnalytical Chemistry & MS-LaserLab\, Vrije Universiteit Amsterdam. PhD jointly sponsored by AstraZeneca\, GSK\, and Novartis\, with funding from the Dutch Research Council (NWO); co-supervised by Anouk Rijs and Govert Somsen. Part of the InnovATOR consortium InnovATOR consortium. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/oligo-hybrid-fragmentation/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/oligo-hybrid-fragmentation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T083000
DTEND;TZID=America/Los_Angeles:20260722T143000
DTSTAMP:20260615T164328Z
CREATED:20260615T164328Z
LAST-MODIFIED:20260615T164328Z
UID:10001107-1784709000-1784730600@www.califesciences.org
SUMMARY:Advances in the Development of Therapeutics and Diagnostics for Women’s Health
DESCRIPTION:Join Pharmaceutical & BioScience Society San Francisco Bay and Women in Bio (WIB) San Francisco Bay Area for an online symposium discussing women’s health therapeutics and diagnostics. \nSpeakers’ Bios\nDr. Julie Andersen is a Professor at the Buck Institute. She has published more than 200 scientific papers and holds several patents on work from her laboratory. Dr. Andersen has been recognized for her research with a Glenn Award and a senior scholarship from the Ellison Medical Foundation. She was elected a fellow of the Society for Free Radicals in Biology and Medicine in 2013. She currently serves as an Editor in Chief of the journal Aging Biology. Dr. Andersen has extensive experience working with both biotech companies and medical foundations. \nLaura Esserman\, MD\, MBA is the director of the UCSF Breast Care Center\, and is recognized as a thought leader in cancer screening and over-diagnosis\, as well as innovative clinical trial design. She led the creation of the University of California-wide Athena Breast Health Network\, a learning system designed to integrate clinical care and research as it follows 150\,000 women from screening through treatment and outcomes. The Athena Network launched the PCORI-funded WISDOM Study\, which tests a personalized approach to breast cancer screening in 100\,000 women. She is also a leader of the innovative I-SPY TRIAL model\, designed to accelerate the identification and approval of effective new agents for women with high risk breast cancers. \nMeredith Hartley graduated from Dartmouth College earning her AB degree in Chemistry with high honors. She then earned her PhD in Biological Chemistry at Massachusetts Institute of Technology working with Dr. Barbara Imperiali. Following graduate school\, Dr. Hartley moved to Oregon Health & Science University (OHSU) in Portland\, Oregon as a postdoctoral fellow with Dr. Thomas Scanlan. At OHSU\, she validated the use of thyromimetics for treating diseases of myelin damage in preclinical models of multiple sclerosis and an inborn error of metabolism called X-linked adrenoleukodystrophy.\nDr. Hartley joined the University of Kansas as an Assistant Professor in January 2020. Her laboratory investigates the connections between brain lipids\, hormones\, and myelin with the goal of developing novel therapies for neurological diseases. \nRidhi Tariyal\, BS\, Georgia Tech; MBA\, Harvard University; SM\, MIT; Blavatnik Fellow; Ferolyn Fellow\, is CEO and co-Founder of NextGen Jane. At NextGen Jane\, Ridhi has driven the development of a novel menstrual data platform characterizing uterine biology at a molecular level. In this effort\, she has raised capital\, established an IP position\, and developed a team to create both novel hardware and software to change how women access care. Before NGJ\, Ridhi worked at the Broad Institute and at Bristol Myers Squibb. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/therapeutics-and-diagnostics-for-womens-health/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/therapeutics-and-diagnostics-for-womens-health/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260716T153000
DTEND;TZID=America/Los_Angeles:20260716T183000
DTSTAMP:20260618T154530Z
CREATED:20260618T154530Z
LAST-MODIFIED:20260618T154530Z
UID:10001112-1784215800-1784226600@www.califesciences.org
SUMMARY:MBC BioLabs Planetary Health Block Party
DESCRIPTION:Join MBC BioLabs and friends for an afternoon of planetary health science\, community\, and summer fun. We’re bringing together the researchers\, founders\, funders\, and supporters building lab-forward solutions for our climate\, agriculture\, and environment\, all under one tent in San Carlos. \nThis is your invitation to meet the people working on what comes next when biotech meets climate tech. \nWhat to Expect\n\nSoap box stories. Climate leaders take the mic for two-minute lightning talks on what drew them into the climate movement\, the impact they hope to leave\, and their personal theory of change. Expect candor\, conviction\, and the occasional curveball.\nActivate Planetary Health Green Ticket 2026. We’ll announce the winner of the Activate Ticket — a full year of bench space and core facility access at our 733 Industrial campus\, awarded to an early-stage company developing lab-enabled solutions for climate and agriculture. Selected by a panel of fellow climate supporters\, this award is our way of putting real resources behind the science that can move the needle.\nLab tours. Get a behind-the-scenes look at the science happening every day at 733 Industrial Rd.\nLawn games\, food truck\, and chill summer vibes. Spike ball\, cornhole\, ping pong\, basketball\, a DIY photo booth\, and food truck eats.\n\nAgenda\n\n3:30 PM Doors open\, games and food kicks off\n4:30 PM Soap box stories by:\n\nTerraferma: an AI-biomanufacturing company focused on efficient protein production.\nRuby Bio: a proprietary biomanufacturing platform putting performance first\, sustainably.\n\n\n5:00 PM Activate Planetary Health Green Ticket 2026 winner announced\n5:15 PM Lab tours\n6:30 PM That’s a wrap\n\nWho should come\nAnyone building\, funding\, advising\, or cheering on climate and ag tech is welcome. The event is open and inclusive to all who support a healthy and vibrant planet. \nHow to get here\nWe’re just a 10-minute walk from the San Carlos Caltrain station. We also have bike racks for the green commuters out there. \nREGISTER» \nHosted by: \nMBC BioLabs offers flexible lab-space for ambitious biotech companies tackling today’s biggest challenges. We believe entrepreneurs can and will change our lives – we aim to help them do it faster\, smarter and with a little more fun along the way. \nBits in Bio is a global community at the intersection of software and the life sciences\, connecting computational experts with biologists to accelerate the bioeconomy. With 5\,000+ members across 15+ cities worldwide\, it operates as a neutral\, non-profit platform serving everyone from big biopharma veterans to first-timers exploring computational biology — through events\, job postings\, mentorship\, and a thriving online network.
URL:https://www.califesciences.org/event/mbc-biolabs-planetary-health-block-party/
LOCATION:733 Industrial Rd\, 733 Industrial Rd\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Community Initiatives & Programs,Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260715T120000
DTEND;TZID=America/Los_Angeles:20260715T130000
DTSTAMP:20260709T155500Z
CREATED:20260709T155500Z
LAST-MODIFIED:20260709T155500Z
UID:10001121-1784116800-1784120400@www.califesciences.org
SUMMARY:Mitigating Data Bias for Life Science Models
DESCRIPTION:You downloaded the dataset and the bias came with it. Unless you catch it\, it flows straight into your model\, your paper\, and the decision at the end. \n​This 60-minute session is for life-sciences researchers and managers who use public and private datasets and know the history of those datasets. We work through a practical arc you can run from detecting the bias you inherited\, mitigating what is fixable in the data you already have\, and designing collection so the next dataset does not repeat it. \n​We ground it in real\, recent cases like a polygenic score or a skewed biobank. You will leave with a repeatable four-question scan for any dataset\, a working sense of which fixes rescue biased data and which do not\, and a short list of design habits. \n​No coding required. Bring a dataset you actually work with. \n​Who this is for: Post-docs\, research scientists\, PIs\, and anyone in life sciences who collects data. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/mitigating-data-bias-for-life-science-models/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/mitigating-data-bias-for-life-science-models/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260715T120000
DTEND;TZID=America/Los_Angeles:20260715T130000
DTSTAMP:20260701T184133Z
CREATED:20260701T184133Z
LAST-MODIFIED:20260701T184133Z
UID:10001119-1784116800-1784120400@www.califesciences.org
SUMMARY:Advanced Cell Culture with Corning
DESCRIPTION:Join MBC Biolabs for a Lunch & Learn on Corning’s latest innovations in advanced cell culture. \nThis session will cover disease modeling techniques\, cutting-edge cell culture models\, and the use of 3D systems to improve assay relevance. \nLearn how these solutions can enhance biological accuracy\, streamline workflows\, and support better decision-making in your research—all while enjoying lunch and connecting with Corning. \nREGISTER»
URL:https://www.califesciences.org/event/advanced-cell-culture-with-corning/
LOCATION:135 Mississippi St\, 135 Mississippi St\, San Francisco\, CA\, 94118\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260715T100000
DTEND;TZID=America/Los_Angeles:20260715T150000
DTSTAMP:20260709T193459Z
CREATED:20260618T154144Z
LAST-MODIFIED:20260709T193459Z
UID:10001111-1784109600-1784127600@www.califesciences.org
SUMMARY:MBC BioLabs X American Red Cross Blood Drive
DESCRIPTION:Open to everyone — MBC residents\, guests\, and the wider community. \nEligibility:\nMust be 16+\, weigh at least 110 lbs\, and bring a valid photo ID. Eligibility has expanded in recent years — lifting restrictions on gay and bisexual men\, and people previously deferred for time spent in the UK\, Ireland\, or France. Check redcrossblood.org for full criteria. \nTime Commitment:\nSet aside about 1 hour for Whole Blood or 1.5 hours for Power Red — and plan to relax with a snack afterward! \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/mbc-biolabs-x-american-red-cross-blood-drive/
LOCATION:135 Mississippi St\, 135 Mississippi St\, San Francisco\, CA\, 94118\, United States
CATEGORIES:Community Initiatives & Programs,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260701T120000
DTEND;TZID=America/Los_Angeles:20260701T130000
DTSTAMP:20260625T185018Z
CREATED:20260625T185018Z
LAST-MODIFIED:20260625T185018Z
UID:10001117-1782907200-1782910800@www.califesciences.org
SUMMARY:Founders at Work: Pasture Biosciences
DESCRIPTION:Next generation cattle vaccines for more productive and sustainable beef and dairy \n​Matt Zehnder\, Founder and CEO of Pasture Biosciences\, is building a new class of livestock vaccines by combining AI-guided design with RNA technology. In this talk\, he’ll share how Pasture is targeting health and productivity challenges in beef and dairy cattle that have long resisted conventional vaccine approaches\, and what that means for the future of animal health and sustainability. \nAbout Founders at Work\nThis monthly seminar series alternates between our San Francisco and San Carlos locations and showcases a distinguished current resident or alumnus from our community. These sessions are designed to provide early-stage founders with real-world advice\, practical strategies\, and inspiring stories from those who’ve navigated the entrepreneurial journey successfully. \nThis event is open to the public. Please be sure to register to reserve your spot! \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/founders-at-work-pasture-biosciences/
LOCATION:MBC BioLabs – San Francisco\, 135 Mississippi St\, San Francisco\, CA\, 94107
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260701T120000
DTEND;TZID=America/Los_Angeles:20260701T130000
DTSTAMP:20260609T175454Z
CREATED:20260609T175454Z
LAST-MODIFIED:20260609T175454Z
UID:10001101-1782907200-1782910800@www.califesciences.org
SUMMARY:Reading the Literature in the Age of AI
DESCRIPTION:​AI literature tools are already inside your research workflow. The question is whether you know what they’re not showing you. \n​This is 60-minute virtual session for life sciences researchers who use AI tools to find\, synthesize\, or evaluate scientific literature — and want to engage with those tools more critically. \n​We open with a real published case: a Nature Communications paper that passed peer review\, generated 22\,000 views\, and contained hundreds of errors. The correction received almost none of the attention. We’ll use it to build four specific failure mechanisms that apply to every AI literature tool you use — and a set of habits that let you catch them before they propagate into your work. \n​The session ends with a live workshop: run a real research question through two different AI tools\, compare what surfaces and what doesn’t\, and identify the failure mechanisms in action. \n​No technical background needed. Just bring a research question you’d actually use. \n​Who this is for: Post-docs\, research scientists\, PIs\, and anyone in life sciences who uses AI tools for literature search\, synthesis\, or research evaluation. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/reading-the-literature-in-the-age-of-ai/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/reading-the-literature-in-the-age-of-ai/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260701T100000
DTEND;TZID=America/New_York:20260701T110000
DTSTAMP:20260511T174029Z
CREATED:20260511T174029Z
LAST-MODIFIED:20260511T174029Z
UID:10001086-1782900000-1782903600@www.califesciences.org
SUMMARY:Streamlining Nonclinical Development with FDA NAMs
DESCRIPTION:FDA’s draft guidance on the validation of New Approach Methodologies (NAMs) is reshaping how nonclinical programs are designed and justified. This webinar explores how sponsors can apply NAMs to streamline development\, improve human relevance\, and support IND decision-making within a weight-of-evidence framework. \nWe will break down FDA expectations for validation\, including context of use and fit-for-purpose application\, and show how to position NAMs effectively in regulatory interactions. \nThrough real-world case examples spanning in vitro\, in silico\, and data-driven approaches\, attendees will gain practical insight into how NAMs can address data gaps\, reduce reliance on traditional models\, and strengthen nonclinical programs. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/streamlining-nonclinical-development-with-fda-nams/
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/streamlining-nonclinical-development-with-fda-nams/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260626T084500
DTEND;TZID=America/Los_Angeles:20260626T173000
DTSTAMP:20260506T221429Z
CREATED:20260506T221429Z
LAST-MODIFIED:20260506T221429Z
UID:10001085-1782463500-1782495000@www.califesciences.org
SUMMARY:Advanced ADME/PK Biopharma LC-MS/MS Method Development Training
DESCRIPTION:This one-day advanced ADME/PK biopharma LC–MS/MS method development training lab course builds on prior mass spectrometry fundamentals with a focus on workflow optimization and practical application on the Sciex platform. The program begins with a recap of prior training and defined learning objectives\, followed by a strategic overview of ADME/PK method development\, including translating project goals into LC–MS/MS workflows\, balancing throughput and data quality\, and selecting between triple quadrupole and HRMS platforms. \nParticipants then rotate through hands-on stations featuring QTRAP and ZenoTOF systems\, covering method setup and submission strategies across multiple acquisition modes. The afternoon sessions focus on data interpretation\, including quantitation using SCIEX-OS\, qualitative versus quantitative workflows\, and instrument readiness. The course concludes with an overview of advanced workflows—such as metabolite identification\, high-throughput analysis\, intact and ICE-IEF approaches\, and biotherapeutics-related methods—followed by closing reflections and discussion of future curriculum topics. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advanced-adme-pk-biopharma-lc-ms-ms-method-development-training/
LOCATION:SCIEX\, 1201 Radio Road\, Redwood City\, CA\, 94065\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T173000
DTEND;TZID=America/Los_Angeles:20260624T190000
DTSTAMP:20260617T155944Z
CREATED:20260617T155944Z
LAST-MODIFIED:20260617T155944Z
UID:10001110-1782322200-1782327600@www.califesciences.org
SUMMARY:UC Santa Cruz Biotech Reception
DESCRIPTION:Please join us on June 24\, 2026\, at 5:30 pm at the Hard Rock Hotel San Diego\, for a special reception with UC Santa Cruz Nobel Laureate Carol Greider and members of the UCSC Department of Molecular\, Cell and Developmental Biology faculty. \nCarol won the Nobel Prize in 2009 for discovering how the tips of our chromosomes — called telomeres — protect the DNA inside our cells. Think of telomeres like the plastic caps on shoelaces that keep them from fraying. She also discovered telomerase\, the enzyme that rebuilds these caps as our cells divide. Her work has transformed how scientists understand aging\, cancer\, and what keeps our cells healthy over a lifetime. \nThis event is open to all UC Santa Cruz Alumni\, San Diego area supporters\, and interested industry representatives in town for the BIO International Convention. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/uc-santa-cruz-biotech-reception/
LOCATION:Hard Rock Hotel San Diego\, 207 5th Avenue\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T170000
DTEND;TZID=America/Los_Angeles:20260624T193000
DTSTAMP:20260622T155437Z
CREATED:20260622T155437Z
LAST-MODIFIED:20260622T155437Z
UID:10001113-1782320400-1782329400@www.califesciences.org
SUMMARY:AI for Population Health
DESCRIPTION:Join Leah Makley\, MBC’s Chief Operating Officer and Lee Sanders\, MD\, MPH\, from Stanford University School of Medicine for “AI for Population Health: Nurturing Science for Longer\, Healthier Lives” \n​This conversation explores how artificial intelligence is reshaping population health by turning large-scale biological\, clinical\, environmental\, and behavioral data into actionable insights that can improve outcomes across entire communities. \n​Focusing on the theme of “nurturing science for everyone to live the longest\, healthiest life\,” we will discuss how modern AI methods\, ranging from predictive modeling to causal inference and multimodal data integration. are enabling earlier disease detection\, more precise risk stratification\, and more effective prevention strategies at scale. Special attention will be given to how these tools can be translated from research settings into real-world impact through biotech innovation\, healthcare partnerships\, and data infrastructure. For the MBC BioLabs community\, the session will highlight opportunities and challenges in building responsible\, scalable AI systems that not only advance scientific discovery but also meaningfully reduce health disparities and extend healthy lifespan across diverse populations. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/ai-for-population-health/
LOCATION:1030 Brittan Ave\, 1030 Brittan Ave\, San Carlos\, CA\, 94070\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T100000
DTEND;TZID=America/Los_Angeles:20260624T113000
DTSTAMP:20260622T155809Z
CREATED:20260622T155809Z
LAST-MODIFIED:20260622T155809Z
UID:10001114-1782295200-1782300600@www.califesciences.org
SUMMARY:ACROBiosystems GMP Factory Online Open Day
DESCRIPTION:Join our GMP Factory Online Open Day and explore how our intelligent manufacturing operations\, globally compliant quality systems\, and end-to-end production capabilities support biologics development worldwide. \n🔹 Virtual GMP facility tour\n🔹 Insights into quality management and compliance\n🔹 Meet our process development and quality experts\n🔹 Explore custom development and collaboration opportunities \nAs part of our sustainability commitment\, ACROBiosystems will plant a tree through One Tree Planted for every attendee. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/acrobiosystems-gmp-factory-online-open-day/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/acrobiosystems-gmp-factory-online-open-day/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260623T120000
DTEND;TZID=America/Los_Angeles:20260623T131500
DTSTAMP:20260526T160417Z
CREATED:20260526T160417Z
LAST-MODIFIED:20260526T160417Z
UID:10001093-1782216000-1782220500@www.califesciences.org
SUMMARY:The AI Data Layer: Building Trust\, Accuracy\, and Scale in Life Sciences
DESCRIPTION:Join Springer Nature for a free lunch event during BIO!\n​As biotech and pharma organizations accelerate adoption of AI across discovery\, R&D\, medical affairs\, and knowledge workflows\, the foundation for success is becoming clear: specialized\, vetted\, and well-structured scientific data underpins the most reliable outcomes and insights from AI systems. \n​Join Dr. Prathik Roy\, Product Director of AIGP Solutions at Springer Nature\, for an exclusive off-site lunch event during the BIO International Convention. The session will explore: \n\n​How semantically enriched scientific content improves downstream AI performance\n​Delivery of scientific data through scalable architectures\, including APIs\, MCP\, and private cloud deployments\n​Approaches for enabling secure\, copyright-cleared enterprise AI applications\n​How trusted scientific literature serves as an integration-ready “data layer” for retrieval-augmented generation (RAG)\, model development\, and agentic AI systems\n​Practical strategies for life sciences organizations to reduce risk in AI implementation\, strengthen the quality of outputs and build trusted infrastructure\n\n​Attendees will gain a candid\, real-world perspective grounded in experience across scientific publishing\, R&D\, and AI-enabled content access. This event is free and lunch will be provided. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-ai-data-layer-building-trust-accuracy-and-scale-in-life-sciences/
LOCATION:Huntress\, 376 Fifth Ave\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260626
DTSTAMP:20260507T160427Z
CREATED:20251117T211711Z
LAST-MODIFIED:20260507T160427Z
UID:10000949-1782086400-1782431999@www.califesciences.org
SUMMARY:BIO International Convention 2026
DESCRIPTION:This is the force that unites us—not the pursuit of status or stability\, but the unwavering conviction to solve the impossible\, to push boundaries\, and to achieve better outcomes for patients\, public health\, and the world. \nBIO 2026 is where we return to this essential “why.” It is our opportunity to reconnect as a global community\, to recharge our commitment\, and to remember that behind every innovation is a shared mission: to improve lives. \nConnect with the global biotech community in San Diego June 22-25\, 2026. \nLEARN MORE»
URL:https://www.califesciences.org/event/bio-international-convention-2026/
LOCATION:San Diego Convention Center\, 111 W Harbor Dr\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260623
DTSTAMP:20260506T201002Z
CREATED:20260506T201002Z
LAST-MODIFIED:20260506T201002Z
UID:10001079-1782086400-1782172799@www.califesciences.org
SUMMARY:RESI San Diego
DESCRIPTION:RESI San Diego 2026 will take place on June 22 at the JULEP Venue San Diego during the Convention Week\, followed by FOUR (4) days of virtual partnering on June 23-24\, 29-30. Virtual partnering on the June 29-30 gives you a chance to extend your Convention-week partnering! This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. \n\nCLS members receive a $200 discount on tickets and IPC packages. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/resi-san-diego/
LOCATION:JULEP Venue\, 1735 Hancock St\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260618T073000
DTEND;TZID=America/Los_Angeles:20260618T090000
DTSTAMP:20260520T223248Z
CREATED:20260520T223208Z
LAST-MODIFIED:20260520T223248Z
UID:10001090-1781767800-1781773200@www.califesciences.org
SUMMARY:Advanced AI for Life Sciences
DESCRIPTION:On June 18th\, Hands On and the Healthcare Businesswomen’s Association are hosting a virtual\, advanced session on AI in Life Sciences. \nHBA and non-HBA members are all welcome to attend. \nAs AI is brought more widely into use\, discover how to adopt and integrate it into your work\, whether you work in R&D\, Tech Ops\, Medical Affairs\, Commercial or G&A. \nFacilitated by an AI expert in life sciences. This session will cover: \n\n\n\nLatest trends in AI\nPragmatic applications\nWhy AI projects succeed and fail\nCurrent AI issues\n\n\n\n\nThe Future of AI\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advanced-ai-for-life-sciences/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/advanced-ai-for-life-sciences/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T120000
DTEND;TZID=America/Los_Angeles:20260617T130000
DTSTAMP:20260609T175230Z
CREATED:20260609T175230Z
LAST-MODIFIED:20260609T175230Z
UID:10001100-1781697600-1781701200@www.califesciences.org
SUMMARY:How to Build a Working AI System in Life Sciences – Virtual
DESCRIPTION:​Everyone in life sciences has been told to use AI. Most have not been shown properly how. \n​This is a 60-minute hands-on session for life sciences professionals who want to actually understand what AI systems do and leave having built one. \n​We’ll cover the mental model that makes everything else click: how AI systems process information\, why the tools you use behave the way they do\, and how to write instructions that produce reliable outputs. Then you’ll build a working AI agent around an example provided. No coding experience required. \n​Be ready with your LLM of choice\, and one problem you’d like AI to help with. You’ll leave with something that works. \n​Who this is for: R&D professionals\, clinicians\, post-docs\, research scientists\, and anyone in life sciences who works with AI tools and wants to understand them better. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-build-a-working-ai-system-in-life-sciences-virtual/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/how-to-build-a-working-ai-system-in-life-sciences-virtual/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T090000
DTEND;TZID=America/Los_Angeles:20260617T100000
DTSTAMP:20260603T171823Z
CREATED:20260603T171823Z
LAST-MODIFIED:20260603T171823Z
UID:10001096-1781686800-1781690400@www.califesciences.org
SUMMARY:From Breakthrough to Bedside: Aligning Regulatory Strategy\, Clinical Evidence and Commercialization in Diagnostics
DESCRIPTION:This panel will examine how diagnostics innovators can effectively move from concept to market adoption. The discussion will cover critical intersections between regulatory strategy\, clinical validation and commercialization\, including FDA pathways\, clinical study design and how to position programs for investment and scale. \nSpeakers include:\n› Sarah Melaney\, Pillsbury Partner (Moderator)\n› Steven Green\, Pillsbury Partner (Panelist)\n› Joen Johansen\, President & CEO of MDC Associates (Panelist)\n› Michele Colucci\, Founding Managing Partner of DigitalDX (Panelist) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-breakthrough-to-bedside-aligning-regulatory-strategy-clinical-evidence-and-commercialization-in-diagnostics/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/from-breakthrough-to-bedside-aligning-regulatory-strategy-clinical-evidence-and-commercialization-in-diagnostics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T113000
DTEND;TZID=America/Los_Angeles:20260617T170000
DTSTAMP:20260609T155617Z
CREATED:20260609T155617Z
LAST-MODIFIED:20260609T155617Z
UID:10001098-1781609400-1781715600@www.califesciences.org
SUMMARY:Accelerating Advanced Therapies
DESCRIPTION:Progress in advanced therapies isn’t achieved in isolation. It’s shaped through shared expertise\, practical experience\, and meaningful collaboration. \nJoin Cytiva specialists and industry peers on June 16 & 17th for Accelerating Advanced Therapies\, an immersive\, in-person event centered on partnership\, insight\, and hands-on innovation across genomic medicine development and manufacturing. \nThrough practical learning and real-world discussion\, this event moves beyond theory to help you drive progress in an increasingly complex genomic medicine landscape. \n\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/accelerating-advanced-therapies/
LOCATION:10300 Campus Point Dr\, 10300 Campus Point Dr\, San Diego\, CA\, 92121\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T100000
DTEND;TZID=America/Los_Angeles:20260616T110000
DTSTAMP:20260526T160015Z
CREATED:20260526T160015Z
LAST-MODIFIED:20260526T160015Z
UID:10001092-1781604000-1781607600@www.califesciences.org
SUMMARY:Leveraging AI and Research Platforms to Accelerate Next-Generation Biological Modalities
DESCRIPTION:As biologic modalities such as in vivo CAR therapies and antibody-drug conjugates (ADCs) rapidly advance\, the need for efficient and scalable development solutions continues to grow. \nJoin our webinar to explore how AI-enabled protein engineering\, optimized reagents\, and advanced assay platforms can support translational research\, improve reproducibility\, streamline manufacturing\, and accelerate next-generation cancer therapeutics development. \nKey highlights include:\n🔹 AI-powered protein engineering and advanced assay solutions\n🔹 Tools to improve protein interaction studies\, reproducibility\, and translational research\n🔹 Strategies to accelerate next-generation cancer therapeutic development \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/leveraging-ai-and-research-platforms-to-accelerate-next-generation-biological-modalities/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/leveraging-ai-and-research-platforms-to-accelerate-next-generation-biological-modalities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260611T084500
DTEND;TZID=America/Los_Angeles:20260611T173000
DTSTAMP:20260506T221126Z
CREATED:20260506T221126Z
LAST-MODIFIED:20260506T221126Z
UID:10001084-1781167500-1781199000@www.califesciences.org
SUMMARY:Antibody Preclinical Development & IND Filing: Nuts\, Bolts\, Best Practices and Regulatory Strategies
DESCRIPTION:The investigational new drug application (IND) application is an important step in a drug development program\, and understanding the requirements for a successful IND filing is utmost important to ensure fast and efficient development. While the principles and basics are similar across different modalities for an IND filing such as safety studies\, there are important aspects that need to be considered for antibody-based therapeutics (antibodies\, antibody-drug conjugates and multispecific antibodies). In this workshop\, our highly experienced speakers from industry and the FDA will discuss the necessary preclinical studies for an antibody candidate and the best practices and regulatory strategies for a successful IND package of an antibody candidate. \nOutline: \n\nOverview of antibody-based therapeutics: structure\, generation\, design\, and optimization\nOverview of preclinical development and IND filing requirements for antibody-based therapeutics\nNon-clinical pharmacology considerations antibodies and in vivo disease modeling\nPharmacokinetic/Pharmacodynamic and bioanalytical considerations for successful IND filings\nHuman dose projection through clinpharm quantitative modeling\nPreclinical toxicology studies\nIND-enabling CMC activities\nClinical Development Plan\nRegulatory strategies and interactions with FDA: Industry perspective & how to prepare for FDA meetings\nThe regulatory perspective: the do’s and don’ts and avoiding a clinical hold\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/antibody-preclinical-development-ind-filing/
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Blvd\, Burlingame\, CA\, 94010\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T170000
DTEND;TZID=America/Los_Angeles:20260610T200000
DTSTAMP:20260601T225930Z
CREATED:20260601T225930Z
LAST-MODIFIED:20260601T225930Z
UID:10001095-1781110800-1781121600@www.califesciences.org
SUMMARY:Beyond the Red Tape: Scaling Connected Health in 2026
DESCRIPTION:As healthcare moves toward proactive\, preventive\, and AI-enabled care models\, the regulatory boundary between “wellness” and “medical device” has been fundamentally redefined. This event brings together leading experts in Regulatory Affairs\, Quality\, Connected Health\, and Digital Health to discuss how organizations can successfully scale connected ecosystems in this new regulatory era. \nKey topics include:\n💡 The 2026 FDA regulatory changes impacting Connected Health and Clinical Decision Support (CDS)\n💡 How companies are navigating the evolving “wellness vs. medical device” boundary\n💡 AI-enabled sensors\, remote monitoring\, and digital health ecosystems\n💡 Using Predetermined Change Control Plans (PCCPs) for AI and software lifecycle management\n💡 Strategies to accelerate innovation while maintaining compliance\n💡 Data validation and regulatory considerations for next-generation connected platforms \n🎤 Featured Speakers:\nRitam Priya — Principal\, Novarum MDRQ Consulting\nWalt Cecka — Medical Technology Fellow\, Triple Ring\nYusi Liu\, RAC.\, SVP of RA and QA\, BioIntelliSense Inc.\nJeanne Zhang\, Principal Regulatory Affairs Specialist\, MiniMed\nAarti Shukla\, M.S.Rsc\, RAC\, Regulatory Affairs\, Roche \n🤝 The evening will also include networking opportunities and an exclusive facility tour of Triple Ring Technologies. \nWhether you work in Regulatory Affairs\, Quality\, Digital Health\, MedTech\, AI\, Software\, or Connected Devices\, this is a conversation you won’t want to miss. \nHosted by:
URL:https://www.califesciences.org/event/beyond-the-red-tape-scaling-connected-health-in-2026/
LOCATION:Triple Ring Technologies\, 39655 Eureka Dr\, Newark\, CA\, 94560\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260610T170000
DTEND;TZID=America/Los_Angeles:20260610T193000
DTSTAMP:20260609T174947Z
CREATED:20260609T174947Z
LAST-MODIFIED:20260609T174947Z
UID:10001099-1781110800-1781119800@www.califesciences.org
SUMMARY:How to Build a Working AI System in Life Sciences
DESCRIPTION:Everyone in life sciences has been told to use AI. Most have not been shown properly how. \n​This is a 90-minute hands-on session for life sciences professionals who want to actually understand what AI systems do and leave having built one. \n​We’ll cover the mental model that makes everything else click: how AI systems process information\, why the tools you use behave the way they do\, and how to write instructions that produce reliable outputs. Then you’ll build a working AI agent around a task from your own workflow. No coding experience required. \n​Bring a laptop\, your LLM of choice\, and one problem you’d like AI to help with. You’ll leave with something that works. \n​Who this is for: R&D professionals\, clinicians\, post-docs\, research scientists\, and anyone in life sciences who works with AI tools and wants to understand them better. \n​Agenda: \n​5:00-5:30p: Sign in \n​5:30-7:00p: Workshop \n​7:00-7:30p: Networking (NA beverages and light snacks) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-build-a-working-ai-system-in-life-sciences/
LOCATION:San Francisco\, San Francisco\, CA\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
END:VCALENDAR